A study examines quality of life and depression after CAR-T for hematological malignancies

Published Date: 12 Apr 2023

In adults with hematological malignancies receiving chimeric antigen T-cell receptor (CAR-T) therapy, quality of life (QoL) deteriorates, and physical and psychological symptoms worsen one week after infusion and then improve...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

2.

Error on the MGUS-Autoimmune Disease Association.

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Unified Neuro/Psych Residency Program: New Proposal.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot